Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.

Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

artificial intelligence AI in healthcare

Industry Watcher’s Digest

An influential industry group, AdvaMed, really likes President-Elect Trump’s choice of Dr. Oz for CMS administrator. 

patient engagement satisfaction

5 ways to let AI raise patient satisfaction, elevate provider performance

It’s been years since AI proponents started promising big returns on healthcare providers’ investments in the technology. The results have yet to catch up with the pitches. What’s the holdup? 

artificial intelligence AI in healthcare

Industry Watcher’s Digest

Black-box outputs aren’t just a problem with AI. They’re also a problem with physicians. 

artificial intelligence AI life sciences biopharma

When life sciences met artificial intelligence

The pace of AI adoption is quickening in the sector, which includes biopharmaceuticals, digital health, clinical diagnostics and medical devices.

Orano Med breaks ground on $265M thorium production site

The new 7,000-square-meter plant is located in France and will begin production of thorium-228, necessary for the development of isotopes used in cancer treatments. 

DEA, HHS extend telehealth controlled substance prescription rule

The COVID-era flexibility has been extended until 2026 as the DEA and HHS work on a permanent fix that will appease regulators and providers alike. 

Main bridge access into the facility that was heavily damaged by the flooding. Photo by Aerial Lens.

Baxter reopens second production line at North Carolina IV solutions site

The plant is now operating at 50% of its pre-Hurricane Helene levels, as Baxter aims to reach full capacity by the end of the year.